Your trusted source for investing success

Tag: Aurinia Pharmaceuticals

An Introduction to TSXV Life Science Stocks

An Introduction to TSXV Life Science Stocks

Should you decide that the TSXV is right for you, the Investing News Network has compiled a list of some medical device, genetics, pharmaceutical and biotech stocks currently trading on this exchange—as well as their area of focus.

Aurinia Announces That Voclosporin Achieves Primary Endpoints

Aurinia Pharmaceuticals today announced that in addition to voclosporin (23.7 mg BID) achieving its primary endpoint of Complete Remission (CR) at 24 weeks, both doses of voclosporin when added to the current standard of care of Mycophenolate Mofetil (MMF) and a forced oral corticosteroid taper have met all 24-week pre-specified

Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
5 Top NASDAQ Biotech Stocks: Collegium Wins the Week

URL: https://investingnews.com/daily/life-science-investing/biotech-investing/weekly-top-nasdaq-biotech-stocks/